Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Search
Search
Trending Articles
Loftware and RiseNow partner to strengthen supply chain traceability and compliance in healthcare settings
The alliance pairs Loftware's SAP-integrated product identification platform with RiseNow's procurement and supply chain advisory services, delivering end-to-end track-and-trace capabilities for regulated industries where audit readiness and patient safety are critical
Hanmi licenses UCN2 obesity drug candidate HM17321 to Genentech in $2.3bn deal
Hanmi Pharm has granted Genentech global rights to develop and commercialise HM17321, an investigational UCN2 analogue designed to drive weight loss while preserving lean mass
CEPI announces $4.17m for studies assessing existing Ebola vaccines against Bundibugyo strain
Four CEPI-backed research projects will analyse thousands of stored blood samples to determine whether vaccines against Zaire ebolavirus, including Ervebo, generate immune responses to Bundibugyo ebolavirus
FairJourney Bio engineers tumour-conditional IL-12 switch to improve therapeutic window
The company has engineered a dual-specificity antibody fragment designed to activate IL-12 selectively in the tumour microenvironment, with preclinical data and quantitative systems pharmacology modelling indicating potential for reduced systemic toxicity
AlzeCure receives $12m upfront as NeuroRestore Alzheimer's platform licensing deal with QuantumCell closes
The payment — comprising $7m in licence fees and $5m direct investment — kicks off a collaboration worth more than $2.2bn in potential milestones, with QuantumCell assuming global rights to ACD856 and the NeuroRestore platform
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all
You may also like
Hi Tech Manufacturing
Rapid access to custom liquid and powder media helps scientists move from formulation design to process decisions faster, while supporting a clearer path to future GMP...
Lonza launches rapid custom media prototyping service to accelerate early bioprocess development
Read more
Sustainability
Discover how the NSF QP Alumni community provides broader industry perspective, trusted connections and fresh insight
How the right professional community can build confidence as a QP
Read more
Research & Development
AKIR001 is a targeted antibody-radionuclide conjugate designed to deliver radiation directly to CD44v6-expressing solid tumours, with potential to become a first-in-class therapy
Akiram and ITM sign supply agreement to develop AKIR001 to treat solid tumours
Read more
Research & Development
Lupin has recently announced two significant developments, reinforcing its momentum in both the US generics market and its global speciality care strategy
Lupin advances speciality pipeline with FDA approval and European partnership
Read more
Research & Development
Jocasta Neuroscience has secured expanded exclusive rights to UCSF α-klotho intellectual property as it advances JN-0413 towards first-in-human testing for cognitive...
Jocasta expands UCSF α-klotho licence ahead of 2027 Phase I trial
Read more
Manufacturing
Alcami combines deep analytical expertise, flexible manufacturing, and advanced packaging capabilities to deliver a more seamless pathway from development to commercial supply
Strengthening end-to-end capabilities for modern drug development
Read more
Packaging
OPTIMA has published its second CSRD-aligned sustainability report, highlighting progress on renewable energy, emissions management, energy-efficient machinery and information...
OPTIMA expands sustainability drive across machinery portfolio
Read more
Packaging
Artificial intelligence is rapidly transitioning from a technology pipedream to an operational reality for many businesses in the pharmaceutical and medical device...
Why poor data quality has the potential to derail AI in pharma
Read more